To further investigate the relationship between 18F-FDG PET/CT metabolic parameters and HNRNPR expression in patients with ESCA, the IHC staining intensity of HNRNPR in tumor samples was determined, as well as the correlation with SUVmax, SUVmean, TLG, and MTV. This evidence concerns the gene HNRNPR and neoplasm.